Blacks Still Show Lower Statin Treatment Rates than Whites

Use of statins among African Americans in 2015 was lower than among whites, researchers said, suggesting that different perceptions about cardiovascular risk and the drugs’ safety and efficacy could be part of the reason.

The treatment rate among African Americans for whom statins would nominally be indicated was 70.6%, versus 74.8% among whites (P=0.02), according to data from the nationwide Patient and Provider Assessment of Lipid Management (PALM) registry, reported Michael Nanna, MD, of Duke University Medical Center, Durham, North Carolina, and colleagues, in JAMA Cardiology.

“The reasons underlying racial differences in satin therapy are complex, with African American patients differing from white…

Read More

*** This news item is 3rd party content and is included strictly for non-commercial informational purposes.

  • 1